See the DrugPatentWatch profile for jornay
Journeay PM, a medication for the treatment of ADHD, is currently under patent protection. Its generic version is not yet available. The patent expiration timeline for Journeay PM will determine when generic versions can enter the market [1].
When Does Journeay PM's Patent Expire?
The exact date of patent expiration for Journeay PM is not publicly disclosed. However, patent information for pharmaceuticals can often be found through resources that track drug patents and exclusivity periods [1]. Information regarding patent challenges or extensions can also affect the generic availability timeline.
What Happens After the Patent Expires?
Once a drug's patent expires and any other market exclusivities have ended, generic manufacturers can apply to the U.S. Food and Drug Administration (FDA) for approval to market their own versions of the drug. Generic drugs are typically bioequivalent to their brand-name counterparts and are usually offered at a lower cost [2].
Who Makes Journeay PM?
Journeay PM is manufactured by Bausch Health Companies Inc. [3].
What is Journeay PM Used For?
Journeay PM is a prescription medication used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in patients aged 6 years and older [3]. It is taken once daily in the morning and is designed to provide symptom control throughout the day [3].
How Does Journeay PM Work?
Journeay PM is a stimulant medication containing amphetamine [3]. It works by affecting the balance of certain natural substances (neurotransmitters) in the brain that are crucial for controlling hyperactivity and impulsivity [3].
Are There Other Medications for ADHD?
Yes, there are several other medications available for the treatment of ADHD, including other stimulant medications (like methylphenidate-based drugs) and non-stimulant medications [4]. The choice of medication often depends on individual patient needs, response, and tolerability [4].
Can Children Take Generic ADHD Medications?
Once Journeay PM patents expire, generic versions may become available for children and adults treated for ADHD. Generic medications must meet the same strict standards for safety, quality, and effectiveness as brand-name drugs set by regulatory agencies like the FDA [2].
What are the Risks of Taking ADHD Medications?
Like all medications, ADHD treatments, including Journeay PM, can have side effects. Common side effects may include decreased appetite, sleeplessness, stomach ache, and weight loss [3]. More serious risks can include cardiovascular problems, psychiatric symptoms, and potential for misuse or dependence, especially with stimulant medications [3, 4]. It is important to discuss potential risks and benefits with a healthcare provider.
What Information is Available on Drug Patents?
DrugPatentWatch.com is a resource that provides information on drug patents, including patent expiry dates and any ongoing litigation that could affect generic drug entry [1]. This type of information is crucial for understanding when a drug's exclusivity period is expected to end.
Sources
1. DrugPatentWatch.com
2. FDA: Generic Drugs
3. Journeay PM Prescribing Information
4. CDC: Treatment of ADHD